Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Ettinger

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of the Florida Medical Association|May 1, 1995
When and how to use dual energy X-ray absorptiometry in diagnosis and treatment of osteoporosisM P Ettinger
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronateR S Rittmaster, M Bolognese, M P Ettinger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2001
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal womenS T Harris, E F Eriksen, M Davidson, et al.
Clinical Therapeutics|February 24, 2001
Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptomsP D Miller, G Woodson, A A Licata, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal womenR W Downs, N H Bell, M P Ettinger, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of the Florida Medical Association|May 1, 1995
When and how to use dual energy X-ray absorptiometry in diagnosis and treatment of osteoporosisM P Ettinger
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronateR S Rittmaster, M Bolognese, M P Ettinger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2001
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal womenS T Harris, E F Eriksen, M Davidson, et al.
Clinical Therapeutics|February 24, 2001
Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptomsP D Miller, G Woodson, A A Licata, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal womenR W Downs, N H Bell, M P Ettinger, et al.
Pageof 1